Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem.

scientific article published on 9 February 2007

Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem. is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/jcisd/TruchonB07
P356DOI10.1021/CI600426E
P698PubMed publication ID17288412

P2093author name stringChristopher I Bayly
Jean-François Truchon
P433issue2
P921main subjectvirtual screeningQ4112105
P304page(s)488-508
P577publication date2007-02-09
P1433published inJournal of Chemical Information and ModelingQ3007982
P1476titleEvaluating virtual screening methods: good and bad metrics for the "early recognition" problem.
P478volume47

Reverse relations

cites work (P2860)
Q428689074D Flexible Atom-Pairs: An efficient probabilistic conformational space comparison for ligand-based virtual screening
Q42318149A Bayesian Target Predictor Method based on Molecular Pairing Energies estimation.
Q33551124A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval.
Q90642490A Distance-Based Boolean Applicability Domain for Classification of High Throughput Screening Data
Q48298528A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α.
Q103831973A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing
Q64922722A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset.
Q50114279A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents.
Q57457333A facile consensus ranking approach enhances virtual screening robustness and identifies a cell-active DYRK1α inhibitor
Q36804305A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi
Q42675961A novel and efficient ligand-based virtual screening approach using the HWZ scoring function and an enhanced shape-density model
Q51543578A novel, customizable and optimizable parameter method using spherical harmonics for molecular shape similarity comparisons.
Q33484416A statistical framework to evaluate virtual screening
Q53638590A steered molecular dynamics mediated hit discovery for histone deacetylases.
Q39842778Adapting Document Similarity Measures for Ligand-Based Virtual Screening.
Q37549101All-atom/coarse-grained hybrid predictions of distribution coefficients in SAMPL5.
Q36043433An Algorithm to Identify Target-Selective Ligands - A Case Study of 5-HT7/5-HT1A Receptor Selectivity
Q27998664Application of 3D Zernike descriptors to shape-based ligand similarity searching
Q34019272Application of NMR and molecular docking in structure-based drug discovery
Q30539786Automated design of ligands to polypharmacological profiles.
Q59254334Automatic pharmacophore model generation using weighted substructure assignments
Q92134160Bayesian semi-supervised learning for uncertainty-calibrated prediction of molecular properties and active learning
Q27902269Benchmark of four popular virtual screening programs: construction of the active/decoy dataset remains a major determinant of measured performance
Q39094539Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery
Q50593408Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO Receptor.
Q41093798Best of both worlds: on the complementarity of ligand-based and structure-based virtual screening
Q42695674Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set.
Q42639520Bias, reporting, and sharing: computational evaluations of docking methods
Q38910044Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization
Q26864619Blind prediction of HIV integrase binding from the SAMPL4 challenge
Q39525827CS-MINER: A Tool for Association Mining in Binding-Database
Q27902293Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets
Q28484330Can the energy gap in the protein-ligand binding energy landscape be used as a descriptor in virtual ligand screening?
Q55401605Cascade Ligand- and Structure-Based Virtual Screening to Identify New Trypanocidal Compounds Inhibiting Putrescine Uptake.
Q37094597Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules
Q36250876Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold.
Q91343873Chemoinformatics and structural bioinformatics in OCaml
Q47116087Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance
Q35054899Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands
Q35783103Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists.
Q100503937Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery
Q28292041Comparing neural-network scoring functions and the state of the art: applications to common library screening
Q27902270Comparing structural fingerprints using a literature-based similarity benchmark
Q92178374Comparison of Data Fusion Methods as Consensus Scores for Ensemble Docking
Q39909719Comparison of structure fingerprint and molecular interaction field based methods in explaining biological similarity of small molecules in cell-based screens
Q60238441Compound Ranking Based on Fuzzy Three-Dimensional Similarity Improves the Performance of Docking into Homology Models of G-Protein-Coupled Receptors
Q30393891Comprehensive structural and functional characterization of the human kinome by protein structure modeling and ligand virtual screening
Q31155333Computational redesign of bacterial biotin carboxylase inhibitors using structure-based virtual screening of combinatorial libraries.
Q39198542Condorcet and borda count fusion method for ligand-based virtual screening
Q34440071Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors
Q33530647Consensus model for identification of novel PI3K inhibitors in large chemical library
Q38430192Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis
Q56980280Deep learning and virtual drug screening
Q90633197Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches
Q90656648Development of New Methods Needs Proper Evaluation-Benchmarking Sets for Machine Learning Experiments for Class A GPCRs
Q34785475Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding
Q37105057Development of conformation independent computational models for the early recognition of breast cancer resistance protein substrates.
Q28553112Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking
Q52590808Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening.
Q58880968Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
Q35172930Discovery of binding proteins for a protein target using protein-protein docking-based virtual screening
Q34707685Diversity selection of compounds based on 'protein affinity fingerprints' improves sampling of bioactive chemical space
Q34049826Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
Q36098710Docking and scoring with ICM: the benchmarking results and strategies for improvement
Q39096521Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping
Q61815750Drug-induced diabetes type 2: In silico study involving class B GPCRs
Q86706640Dynamics and structural determinants of ligand recognition of the 5-HT6 receptor
Q36053324E-pharmacophore-based virtual screening to identify GSK-3β inhibitors
Q27304699Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.
Q55669060Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction.
Q30585969Enhanced ranking of PknB Inhibitors using data fusion methods
Q42320200Enhancing Virtual Screening Performance of Protein Kinases with Molecular Dynamics Simulations
Q50940415Enhancing the Reliability of GPCR Models by Accounting for Flexibility of Their Pro-Containing Helices: the Case of the Human mAChR1 Receptor.
Q30959752Enrichment assessment of multiple virtual screening strategies for Toll-like receptor 8 agonists based on a maximal unbiased benchmarking data set.
Q39951742Estimation of the applicability domain of kernel-based machine learning models for virtual screening
Q30367162Evaluating docking programs: keeping the playing field level.
Q37518530Evaluation of DOCK 6 as a pose generation and database enrichment tool
Q27998703Evaluation of a Bayesian inference network for ligand-based virtual screening
Q37057393Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes?
Q36548489Exploration of multiple Sortase A protein conformations in virtual screening
Q86018664Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling
Q42874590Exploring different virtual screening strategies for acetylcholinesterase inhibitors
Q55309100Extending in Silico Protein Target Prediction Models to Include Functional Effects.
Q27902259Filtered circular fingerprints improve either prediction or runtime performance while retaining interpretability
Q38574930Flexible receptor docking for drug discovery
Q39380258From flamingo dance to (desirable) drug discovery: a nature-inspired approach
Q48875877Fusing Docking Scoring Functions Improves the Virtual Screening Performance for Discovering Parkinson's Disease Dual Target Ligands.
Q30437388GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex
Q47573321GalaxyDock2: protein-ligand docking using beta-complex and global optimization
Q55431831Gene prioritization using Bayesian matrix factorization with genomic and phenotypic side information.
Q91763848Getting Docking into Shape Using Negative Image-Based Rescoring
Q61925358Glossary of terms used in computational drug design, part II (IUPAC Recommendations 2015)
Q96018100High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
Q27000720Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis
Q35676486Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification.
Q54110122How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors.
Q59075291Identification of levothyroxine antichagasic activity through computer-aided drug repurposing
Q35003819Identification of new natural DNA G-quadruplex binders selected by a structure-based virtual screening approach.
Q38771000Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation
Q34219538Identification of selective inhibitors of the potassium channel Kv1.1-1.2((3)) by high-throughput virtual screening and automated patch clamp
Q38720041Identifying ligands at orphan GPCRs: current status using structure-based approaches
Q93362283Implicit-descriptor ligand-based virtual screening by means of collaborative filtering
Q89174818Improving Prediction Accuracy of Binding Free Energies and Poses of HIV Integrase Complexes Using the Binding Energy Distribution Analysis Method with Flattening Potentials
Q90049923Improving the Virtual Screening Ability of Target-Specific Scoring Functions Using Deep Learning Methods
Q64251945In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity
Q92860146In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2
Q42010190In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter
Q93143025Influence of the Structural Accuracy of Homology Models on Their Applicability to Docking-Based Virtual Screening: The β2 Adrenergic Receptor as a Case Study
Q37360048Influence relevance voting: an accurate and interpretable virtual high throughput screening method
Q36496151Inhibiting Helicobacter pylori HtrA protease by addressing a computationally predicted allosteric ligand binding site
Q35932496Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations.
Q28477589Inhibitors of Helicobacter pylori protease HtrA found by 'virtual ligand' screening combat bacterial invasion of epithelia
Q39537370Integrated One-Against-One Classifiers as Tools for Virtual Screening of Compound Databases: A Case Study with CNS Inhibitors
Q35836731Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands
Q60950229Inverse Molecular Docking as a Novel Approach to Study Anticarcinogenic and Anti-Neuroinflammatory Effects of Curcumin
Q90193662Key Topics in Molecular Docking for Drug Design
Q45964832LASSO-ligand activity by surface similarity order: a new tool for ligand based virtual screening.
Q27998705Large scale study of multiple-molecule queries
Q51556600Large-scale computational drug repositioning to find treatments for rare diseases.
Q92669772Ligand-Based Virtual Screening Using Graph Edit Distance as Molecular Similarity Measure
Q34225364Ligand-based virtual screening approach using a new scoring function
Q36316392Ligand-guided homology modelling of the GABAB2 subunit of the GABAB receptor
Q44789723Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach.
Q92221080Ligity: A Non-Superpositional, Knowledge-Based Approach to Virtual Screening
Q112615808MAIP: a web service for predicting blood-stage malaria inhibitors
Q90433761MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo--Lactamase Inhibitors
Q57832782MOLECULAR SIMILARITY ANALYSIS
Q62495870Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review
Q26750642Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening
Q53033714Managing bias in ROC curves.
Q54572862Mapping the 3D structures of small molecule binding sites.
Q36138895Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening
Q50320785Maximizing gain in high-throughput screening using conformal prediction.
Q45943415Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
Q91657657Molecular Architect: A User-Friendly Workflow for Virtual Screening
Q92989414Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti-Mycobacterium ulcerans Natural Product-Derived Compounds
Q36683781Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.
Q27659860Molecular Shape and Medicinal Chemistry: A Perspective
Q37175130Molecular basis for benzodiazepine agonist action at the type 1 cholecystokinin receptor.
Q36002904Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor
Q38828100Molecular graph convolutions: moving beyond fingerprints.
Q92373356Multi-Level Comparison of Machine Learning Classifiers and Their Performance Metrics
Q39535413Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β-Secretase(BACE1).
Q80697151Multiple protein structures and multiple ligands: effects on the apparent goodness of virtual screening results
Q63849411Multivariate class modeling for the verification of food-authenticity claims
Q110391837Natural product drug discovery in the artificial intelligence era
Q57175754Netpredictor: R and Shiny package to perform drug-target network analysis and prediction of missing links
Q48105075Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site.
Q28681290Open-source platform to benchmark fingerprints for ligand-based virtual screening
Q27998698Optimal assignment methods for ligand-based virtual screening
Q34637014Optimization and visualization of the edge weights in optimal assignment methods for virtual screening
Q36343219Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening
Q27902299Optimizing drug–target interaction prediction based on random walk on heterogeneous networks
Q62629057Orphan Drug Legislation with Data Fusion Rules Using Multiple Fingerprints Measurements
Q42696820Orthologue chemical space and its influence on target prediction
Q39513411PL-PatchSurfer2: Improved Local Surface Matching-Based Virtual Screening Method That Is Tolerant to Target and Ligand Structure Variation
Q35668928Pathway-Dependent Effectiveness of Network Algorithms for Gene Prioritization
Q36092217Pharmacophore Alignment Search Tool (PhAST): Significance Assessment of Chemical Similarity
Q60932853Pharmacophore Modeling, Synthesis, and Antibacterial Evaluation of Chalcones and Derivatives
Q33822689Pharmacophore alignment search tool: influence of scoring systems on text-based similarity searching
Q33822695Pharmacophore alignment search tool: influence of the third dimension on text-based similarity searching
Q57458404Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors
Q47587655Pharmacophore modelling, virtual screening and molecular docking studies on PLD1 inhibitors.
Q36087114Pharmacophores in Drug Research.
Q61809823Potential off-target effects of beta-blockers on gut hormone receptors: In silico study including GUT-DOCK-A web service for small-molecule docking
Q59807525PotentialNet for Molecular Property Prediction
Q89993923Practical Model Selection for Prospective Virtual Screening
Q28604323Predicting drug target interactions using meta-path-based semantic network analysis
Q36960746Predicting protein interactions via parsimonious network history inference
Q43124392Predictions of hydration free energies from all-atom molecular dynamics simulations.
Q27902344Predictiveness curves in virtual screening
Q36087023Prioritizing Hits with Appropriate Trade-Offs Between HIV-1 Reverse Transcriptase Inhibitory Efficacy and MT4 Blood Cells Toxicity Through Desirability-Based Multiobjective Optimization and Ranking
Q92811723Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores
Q48498363Progress towards automated Kepler scientific workflows for computer-aided drug discovery and molecular simulations.
Q44012277Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
Q33517871Protein-protein docking using region-based 3D Zernike descriptors
Q112621355QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping
Q57814810Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease
Q36795631Rational prediction with molecular dynamics for hit identification
Q34204731Recognizing pitfalls in virtual screening: a critical review
Q64949997Rescoring and Linearly Combining: A Highly Effective Consensus Strategy for Virtual Screening Campaigns.
Q55093753Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds.
Q45963765Robust optimization of scoring functions for a target class.
Q27902277Rocker: Open source, easy-to-use tool for AUC and enrichment calculations and ROC visualization
Q90559172STarFish: A Stacked Ensemble Target Fishing Approach and its Application to Natural Products
Q57976067Shape-based similarity searching in chemical databases
Q34076210Shape-based virtual screening with volumetric aligned molecular shapes
Q39901298Small molecule hydration free energies in explicit solvent: An extensive test of fixed-charge atomistic simulations
Q43730054Solvation free energies and partition coefficients with the coarse-grained and hybrid all-atom/coarse-grained MARTINI models.
Q28479435Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors
Q41930155Structure based Virtual Screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
Q56854167Structure based virtual screening to discover putative drug candidates: Necessary considerations and successful case studies
Q30435017Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists
Q33934472Structure-based virtual screening of glycogen synthase kinase 3β inhibitors: analysis of scoring functions applied to large true actives and decoy sets.
Q28478200Systematic exploitation of multiple receptor conformations for virtual ligand screening
Q39169235Systemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery
Q28745255The power metric: a new statistically robust enrichment-type metric for virtual screening applications with early recovery capability
Q35571453The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets
Q26801796Three-dimensional compound comparison methods and their application in drug discovery
Q51099469Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance?
Q37014096Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go.
Q30383112Ultra-High-Throughput Structure-Based Virtual Screening for Small-Molecule Inhibitors of Protein-Protein Interactions.
Q28307816Ultrafast shape recognition: method and applications
Q30432445Unleashing the power of meta-threading for evolution/structure-based function inference of proteins
Q47306187Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain
Q37459651Validation of molecular docking programs for virtual screening against dihydropteroate synthase
Q36095634Variability in docking success rates due to dataset preparation
Q51900328Virtual screening applications: a study of ligand-based methods and different structure representations in four different scenarios.
Q52589878Virtual screening by a new Clustering-based Weighted Similarity Extreme Learning Machine approach.
Q28475016Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina
Q51475792Virtual screening for compounds that mimic protein-protein interface epitopes.
Q34626368Virtual screening of chemical libraries for drug discovery
Q30481529What do we know and when do we know it?
Q39531365eFindSite: Enhanced Fingerprint-Based Virtual Screening Against Predicted Ligand Binding Sites in Protein Models
Q27902311vSDC: a method to improve early recognition in virtual screening when limited experimental resources are available

Search more.